Pulmonology
Formoterol Air
Registration certificate:
INN:
Formoterol
Release form:
Metered Dose Inhaler (MDI)
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
Bronchodilator – selective β2-adrenergic agonist
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

  • Prevention and treatment of bronchospasm in patients with moderate to severe bronchial asthma in combination with anti-inflammatory therapy (inhaled or oral corticosteroids).
  • Prevention and treatment of bronchospasm induced by allergens, physical exertion, or cold air as an adjunct to inhaled corticosteroid therapy.
  • Prevention and treatment of bronchial obstruction in patients with chronic obstructive pulmonary disease (COPD).

This medication is included in the List of Essential Medicines.

Using Formoterol Air
Quality control
at all stages of production